SlideShare a Scribd company logo
1 of 4
Download to read offline
M. Pharm (Pharmaceutics)
1
Rahul Pal*, Prachi Pandey
Department of Pharmaceutics, NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan,
India
Object: To determine the pharmacokinetics and pharmacodynamics of propranolol using WinNonlinยฎ
Software.
References:
01. Certara PhoenixTM
software to Pk/PD management and analysis; https://www.certara
.com/software/pkpd.org
02. Pereira, Laiz Compos et. Al, โ€œPharmacokinetic/Pharmacodynamic modeling and app. In
antibacterial/fungal pharmacotherapy: A Narrative reviewโ€, Antibiotics, Vol. 11, (8); pages no.:
986, 22 July 2022, doi: 10.3390/antibiotics11080986.
Requirements:
โ€ข Chemical Moiety: Propranolol
โ€ข Software: Phoenix TM
, WinNonlin (subscription) & trial version also used.
Theory:
WinNonlin software are calculates the pk/pd of drug. Propranolol is beta-blocker uses to treat
hypertension, angina & arrhythmias. To calculate its Pk/Pd through WinNonlin software.
The basics steps of software to determine the PK/PD value with WinNonlin software as following:
โˆ’ Import the data into the WinNonlin software.
โˆ’ Select the appropriate PK/PD Model
โˆ’ Fit the model to your data
โˆ’ Evaluate the model fit
โˆ’ Calculate the PK/PD parameter
โˆ’ Generate the reports
01) Import the data into the WinNonlin software: Import the data into the formats, including CVS,
Excel and Text Files.
M. Pharm (Pharmaceutics)
2
02) Selecting the appropriate pk/pd model: The type of pk/pd selected depends on the drug and the data
have. Some common model as follows:
- One compartment Model
- Two compartment Model
- Michaelis-Menten Model
- Emax. Model.
03) Fitting the model to data: WinNonlin uses variety of methods to fit the models to data, including
least squares methods & the maximum likelihood methods.
04) Evaluating the model fit: When fit the model to data, need to evaluate the model fit. This done by
locking at the residual plots and the R-squared values.
05) Calculating the pk/pd parameter: When evaluation had done of model fit, then calculate the pk/pd
parameters. These parameters tell the drug how much absorbed, distribute, metabolized and
eliminated.
06) Generating the reports: WinNonlin can generate a variety of reports in tables, graphs 7 figure. These
reports can use to communicate the result of analysis to others.
EXPERIMENTAL PROCEDURE: The procedure to determine the PK/PD in the software as following:
01. Import the Data: Open WinNonlin, click on the โ€œfileโ€ menu & select the โ€œimport Dataโ€.
- Select the โ€œtableโ€ option & click on the โ€œnext buttonโ€.
- Select the CSV file that contains your data & click on the
โ€œopenโ€ button.
- The data will be imported into the WinNonlin in a table.
Sr. No. Time (hr.) Concentration (mg/mL)
1 0 100
2 1 80
3 2 60
4 3 40
5 4 20
6 5 00
M. Pharm (Pharmaceutics)
3
02. Selecting the appropriate pk/pd model:
One compartment model: ADME of drug are rapidly absorbed & distributed throughout the body.
Two compartment model: ADME of drug are slowly absorbed & distributed throughout the body.
Michaelis Menten Model: The Relation between the drug conc. & response. It describes the rate of
enzymatic reaction.
Emax. Model: Similar to the Michaelis equation, describes the max. response that drug achieved.
Drug Type Appropriate pk/Pd Model Example
Rapidly
absorption/distribution
One compartmental model Aminoglycosides. Warfarin,
propranolol, insulin
Slowly
absorption/distribution
Two compartmental model Digoxin, phenytoin, theophylline
Drug with a clear dose
response relationship
Michaelis Menten equation Warfarin, penicillin,
acetylcholinesterase
Drug with an all-or-
none response
Emax. Aspirin, chlorpheniramine,
epinephrine and nifedipine
03. Fitting the Appropriate Model to data: Here some of the steps as follows:
a) Open WinNonlin software & create the new project: Go to โ€œFileโ€>New>Project. In the project
dialog box, select the modeling project type & click Ok.
b) Import the plasma conc. & time data into WinNonlin Software: Go to โ€œFile > Import. In the
import dialog box, select the one compartment model type & click Ok.
c) Create the One compartment model in WinNonlin Software: Go to Model > New Model. In
the new model dialog box., select the one compartment model & click Ok.
d) Fill the model to the using data the Non-Linear Regression tools in WinNonlin Software: Go
to model>, in the fit dialog bx, select the non-linear regression tab. In the model field, select the
one compartment model that, created in step. 3. In the data field, select the plasma conc. data that
you imported in step. 2, click Ok.
e) Evaluate the fit of model to data: Go to โ€œView> Fit result, Fit the results the dialog box will
show you the result of non-linear regression fit. Evaluate the fit of model to data.
M. Pharm (Pharmaceutics)
4
f) Save the model & result.
04. Evaluating the Model Fit:
- Residual plots: Good randomly scattered around the line of zero.
- R- Squared Value: A high R2
Value (closer to 1) indicate- Good Fit.
- Low R2 Value (closer to 0) indicate โ€“ Poor fit.
- AIC/BIC: Lowest AIC/BIC mean best fit.
- Visual Inspection: Smooth Curve.
05. Calculating the PK/PD parameters:
- Cl = Dose/AUC
- Vd= AUC/Cmax. โ€“ AUC calculate by the go to.
- T1/2 = 1H (2)/Cl โ€“ โ€œView> Area Under Curveโ€. The area under curve dialog box show
AUC for the fitted model.
06. Generating Reports: The reports generate d of Pk reports includes ADME of drug.
- PD reports for relationship between the drug plasma conc. & effect on blood
pressure.
- Safety reports.
Result: The PK/PD of given beta-blocker propranolol drug has been calculated & graph will plot carefully.
Pharmacokinetics parameters Value of parameters of drug
Cl 10L/h
Vd 50L (4L/kg)
Mean Plasma concentration 100mg/mL
Standard deviation 20mg/mL

More Related Content

What's hot

Validation Of Solid Dosage Forms.
Validation Of Solid Dosage Forms.Validation Of Solid Dosage Forms.
Validation Of Solid Dosage Forms.Ramya priya
ย 
ANDA regulatory approval process
ANDA regulatory approval processANDA regulatory approval process
ANDA regulatory approval processROHIT
ย 
Feedback Regulated DDS
Feedback Regulated DDS Feedback Regulated DDS
Feedback Regulated DDS Aparna Yadav
ย 
Pilot-plant Scale-up Consideration Of Solids by monalisha nayak
Pilot-plant Scale-up Consideration Of Solids by monalisha nayakPilot-plant Scale-up Consideration Of Solids by monalisha nayak
Pilot-plant Scale-up Consideration Of Solids by monalisha nayakGvDurgamani
ย 
Similarity and difference factors of dissolution
Similarity and difference factors of dissolutionSimilarity and difference factors of dissolution
Similarity and difference factors of dissolutionJessica Fernandes
ย 
Compaction profiles
Compaction profilesCompaction profiles
Compaction profilesSiddu K M
ย 
Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)bdvfgbdhg
ย 
MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx
  MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx  MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx
MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptxPawanDhamala1
ย 
Code of Federal Regulations
Code of Federal RegulationsCode of Federal Regulations
Code of Federal RegulationsSwapnil Fernandes
ย 
Drug excipient interaction
Drug excipient interaction Drug excipient interaction
Drug excipient interaction DeeptiGupta154
ย 
Supac - Guidance for Immediate Release Dosage Form
Supac - Guidance for Immediate Release Dosage FormSupac - Guidance for Immediate Release Dosage Form
Supac - Guidance for Immediate Release Dosage FormJubiliant Generics Limited
ย 
New drug approval
New drug approvalNew drug approval
New drug approvalSuvarta Maru
ย 
Activation modulated drug delivery systems
Activation modulated drug delivery systemsActivation modulated drug delivery systems
Activation modulated drug delivery systemsSonam Gandhi
ย 
Drug excepients compatability studies
Drug excepients compatability studiesDrug excepients compatability studies
Drug excepients compatability studieskinju19
ย 

What's hot (20)

Validation Of Solid Dosage Forms.
Validation Of Solid Dosage Forms.Validation Of Solid Dosage Forms.
Validation Of Solid Dosage Forms.
ย 
ANDA regulatory approval process
ANDA regulatory approval processANDA regulatory approval process
ANDA regulatory approval process
ย 
Feedback Regulated DDS
Feedback Regulated DDS Feedback Regulated DDS
Feedback Regulated DDS
ย 
Sr or cr formulations
Sr or cr formulationsSr or cr formulations
Sr or cr formulations
ย 
Ctd and e ctd
Ctd and e ctdCtd and e ctd
Ctd and e ctd
ย 
Pilot-plant Scale-up Consideration Of Solids by monalisha nayak
Pilot-plant Scale-up Consideration Of Solids by monalisha nayakPilot-plant Scale-up Consideration Of Solids by monalisha nayak
Pilot-plant Scale-up Consideration Of Solids by monalisha nayak
ย 
Similarity and difference factors of dissolution
Similarity and difference factors of dissolutionSimilarity and difference factors of dissolution
Similarity and difference factors of dissolution
ย 
Compaction profiles
Compaction profilesCompaction profiles
Compaction profiles
ย 
Concepts of Similarity and Difference factors
Concepts of Similarity and Difference factorsConcepts of Similarity and Difference factors
Concepts of Similarity and Difference factors
ย 
Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)
ย 
Biowaivers
Biowaivers Biowaivers
Biowaivers
ย 
MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx
  MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx  MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx
MECHANISM OF PERMEATION OF DRUG IN BUCCAL DRUG DELIVERY SYSTEM.pptx
ย 
Code of Federal Regulations
Code of Federal RegulationsCode of Federal Regulations
Code of Federal Regulations
ย 
Documentation in Pharmaceutical Industry
Documentation in Pharmaceutical IndustryDocumentation in Pharmaceutical Industry
Documentation in Pharmaceutical Industry
ย 
Targeted drug delivery system
Targeted drug delivery systemTargeted drug delivery system
Targeted drug delivery system
ย 
Drug excipient interaction
Drug excipient interaction Drug excipient interaction
Drug excipient interaction
ย 
Supac - Guidance for Immediate Release Dosage Form
Supac - Guidance for Immediate Release Dosage FormSupac - Guidance for Immediate Release Dosage Form
Supac - Guidance for Immediate Release Dosage Form
ย 
New drug approval
New drug approvalNew drug approval
New drug approval
ย 
Activation modulated drug delivery systems
Activation modulated drug delivery systemsActivation modulated drug delivery systems
Activation modulated drug delivery systems
ย 
Drug excepients compatability studies
Drug excepients compatability studiesDrug excepients compatability studies
Drug excepients compatability studies
ย 

Similar to Determination of PKPD of Drug Using WinNonlin Software.pdf

Pharsight RAS Expertise
Pharsight RAS ExpertisePharsight RAS Expertise
Pharsight RAS ExpertiseMLJReimer
ย 
Session ii g2 lab modeling mmc
Session ii g2 lab modeling mmcSession ii g2 lab modeling mmc
Session ii g2 lab modeling mmcUSD Bioinformatics
ย 
man0 ppt.pptx
man0 ppt.pptxman0 ppt.pptx
man0 ppt.pptxManojKumarr75
ย 
Calculations for Sterile Compounding
Calculations for Sterile Compounding Calculations for Sterile Compounding
Calculations for Sterile Compounding Kdurant36
ย 
RSI_ReportPDF
RSI_ReportPDFRSI_ReportPDF
RSI_ReportPDFAnita Garcia
ย 
Disease Prediction And Doctor Appointment system
Disease Prediction And Doctor Appointment  systemDisease Prediction And Doctor Appointment  system
Disease Prediction And Doctor Appointment systemKOYELMAJUMDAR1
ย 
IRJET - Machine Learning for Diagnosis of Diabetes
IRJET - Machine Learning for Diagnosis of DiabetesIRJET - Machine Learning for Diagnosis of Diabetes
IRJET - Machine Learning for Diagnosis of DiabetesIRJET Journal
ย 
ISA FPID Presentation Final 3
ISA FPID Presentation Final 3ISA FPID Presentation Final 3
ISA FPID Presentation Final 3Paul Brodbeck
ย 
CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor ActivityCoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor ActivityKamel Mansouri
ย 
Meta analysis and spontaneous reporting
Meta analysis and spontaneous reportingMeta analysis and spontaneous reporting
Meta analysis and spontaneous reportinghamzakhan643
ย 
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNING
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNINGA SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNING
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNINGIRJET Journal
ย 
EDUC 215Health and Wellness Project OverviewFor this assignmen
EDUC 215Health and Wellness Project OverviewFor this assignmenEDUC 215Health and Wellness Project OverviewFor this assignmen
EDUC 215Health and Wellness Project OverviewFor this assignmenEvonCanales257
ย 
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...Aldo Shusterman
ย 
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...Aldo Shusterman
ย 
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATIONA SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATIONReshma Fathima .K
ย 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data ManagementDABBETA DIVYA
ย 
E00 program-level modeling and simulation experiences
E00   program-level modeling and simulation experiencesE00   program-level modeling and simulation experiences
E00 program-level modeling and simulation experiencestherealreverendbayes
ย 

Similar to Determination of PKPD of Drug Using WinNonlin Software.pdf (20)

Pharsight RAS Expertise
Pharsight RAS ExpertisePharsight RAS Expertise
Pharsight RAS Expertise
ย 
Session ii g2 lab modeling mmc
Session ii g2 lab modeling mmcSession ii g2 lab modeling mmc
Session ii g2 lab modeling mmc
ย 
man0 ppt.pptx
man0 ppt.pptxman0 ppt.pptx
man0 ppt.pptx
ย 
Calculations for Sterile Compounding
Calculations for Sterile Compounding Calculations for Sterile Compounding
Calculations for Sterile Compounding
ย 
RSI_ReportPDF
RSI_ReportPDFRSI_ReportPDF
RSI_ReportPDF
ย 
Disease Prediction And Doctor Appointment system
Disease Prediction And Doctor Appointment  systemDisease Prediction And Doctor Appointment  system
Disease Prediction And Doctor Appointment system
ย 
IRJET - Machine Learning for Diagnosis of Diabetes
IRJET - Machine Learning for Diagnosis of DiabetesIRJET - Machine Learning for Diagnosis of Diabetes
IRJET - Machine Learning for Diagnosis of Diabetes
ย 
ISA FPID Presentation Final 3
ISA FPID Presentation Final 3ISA FPID Presentation Final 3
ISA FPID Presentation Final 3
ย 
CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor ActivityCoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
ย 
Meta analysis and spontaneous reporting
Meta analysis and spontaneous reportingMeta analysis and spontaneous reporting
Meta analysis and spontaneous reporting
ย 
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNING
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNINGA SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNING
A SURVEY ON BLOOD DISEASE DETECTION USING MACHINE LEARNING
ย 
EDUC 215Health and Wellness Project OverviewFor this assignmen
EDUC 215Health and Wellness Project OverviewFor this assignmenEDUC 215Health and Wellness Project OverviewFor this assignmen
EDUC 215Health and Wellness Project OverviewFor this assignmen
ย 
CO4_2015_LOW_36-39
CO4_2015_LOW_36-39CO4_2015_LOW_36-39
CO4_2015_LOW_36-39
ย 
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
ย 
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
ย 
resumeliliane
resumelilianeresumeliliane
resumeliliane
ย 
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATIONA SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
A SPREADSHEET PROGRAM FOR ONE COMPARTMENT IV BOLUS ADMINISTRATION
ย 
Presentation1
Presentation1Presentation1
Presentation1
ย 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
ย 
E00 program-level modeling and simulation experiences
E00   program-level modeling and simulation experiencesE00   program-level modeling and simulation experiences
E00 program-level modeling and simulation experiences
ย 

More from RAHUL PAL

Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfSoftware Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfRAHUL PAL
ย 
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfRAHUL PAL
ย 
Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfRAHUL PAL
ย 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxRAHUL PAL
ย 
๐Ž๐ซ๐š๐ฅ ๐๐š๐ฉ๐ž๐ซ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง: ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž (๐ˆ๐‘๐“๐„๐‚ ๐Ÿ.๐ŸŽ-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’); The Curre...
๐Ž๐ซ๐š๐ฅ ๐๐š๐ฉ๐ž๐ซ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง: ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž (๐ˆ๐‘๐“๐„๐‚ ๐Ÿ.๐ŸŽ-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’); The Curre...๐Ž๐ซ๐š๐ฅ ๐๐š๐ฉ๐ž๐ซ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง: ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž (๐ˆ๐‘๐“๐„๐‚ ๐Ÿ.๐ŸŽ-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’); The Curre...
๐Ž๐ซ๐š๐ฅ ๐๐š๐ฉ๐ž๐ซ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง: ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž (๐ˆ๐‘๐“๐„๐‚ ๐Ÿ.๐ŸŽ-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’); The Curre...RAHUL PAL
ย 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfRAHUL PAL
ย 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...RAHUL PAL
ย 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...RAHUL PAL
ย 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...RAHUL PAL
ย 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfRAHUL PAL
ย 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptRAHUL PAL
ย 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptRAHUL PAL
ย 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxRAHUL PAL
ย 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)RAHUL PAL
ย 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...RAHUL PAL
ย 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...RAHUL PAL
ย 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...RAHUL PAL
ย 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...RAHUL PAL
ย 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptxRAHUL PAL
ย 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...RAHUL PAL
ย 

More from RAHUL PAL (20)

Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfSoftware Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
ย 
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
ย 
Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdf
ย 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
ย 
๐Ž๐ซ๐š๐ฅ ๐๐š๐ฉ๐ž๐ซ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง: ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž (๐ˆ๐‘๐“๐„๐‚ ๐Ÿ.๐ŸŽ-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’); The Curre...
๐Ž๐ซ๐š๐ฅ ๐๐š๐ฉ๐ž๐ซ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง: ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž (๐ˆ๐‘๐“๐„๐‚ ๐Ÿ.๐ŸŽ-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’); The Curre...๐Ž๐ซ๐š๐ฅ ๐๐š๐ฉ๐ž๐ซ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง: ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž (๐ˆ๐‘๐“๐„๐‚ ๐Ÿ.๐ŸŽ-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’); The Curre...
๐Ž๐ซ๐š๐ฅ ๐๐š๐ฉ๐ž๐ซ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง: ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž (๐ˆ๐‘๐“๐„๐‚ ๐Ÿ.๐ŸŽ-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’); The Curre...
ย 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdf
ย 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
ย 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...
ย 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
ย 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
ย 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.ppt
ย 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
ย 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptx
ย 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
ย 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
ย 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
ย 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
ย 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
ย 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
ย 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...
ย 

Recently uploaded

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
ย 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
ย 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
ย 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
ย 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
ย 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
ย 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
ย 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
ย 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
ย 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
ย 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
ย 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...Sapna Thakur
ย 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
ย 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
ย 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
ย 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
ย 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
ย 
9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room servicediscovermytutordmt
ย 
The byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxThe byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxShobhayan Kirtania
ย 

Recently uploaded (20)

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
ย 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
ย 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
ย 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
ย 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
ย 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
ย 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
ย 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
ย 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
ย 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
ย 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
ย 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
ย 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
ย 
Cรณdigo Creativo y Arte de Software | Unidad 1
Cรณdigo Creativo y Arte de Software | Unidad 1Cรณdigo Creativo y Arte de Software | Unidad 1
Cรณdigo Creativo y Arte de Software | Unidad 1
ย 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
ย 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
ย 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
ย 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
ย 
9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room service
ย 
The byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptxThe byproduct of sericulture in different industries.pptx
The byproduct of sericulture in different industries.pptx
ย 

Determination of PKPD of Drug Using WinNonlin Software.pdf

  • 1. M. Pharm (Pharmaceutics) 1 Rahul Pal*, Prachi Pandey Department of Pharmaceutics, NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan, India Object: To determine the pharmacokinetics and pharmacodynamics of propranolol using WinNonlinยฎ Software. References: 01. Certara PhoenixTM software to Pk/PD management and analysis; https://www.certara .com/software/pkpd.org 02. Pereira, Laiz Compos et. Al, โ€œPharmacokinetic/Pharmacodynamic modeling and app. In antibacterial/fungal pharmacotherapy: A Narrative reviewโ€, Antibiotics, Vol. 11, (8); pages no.: 986, 22 July 2022, doi: 10.3390/antibiotics11080986. Requirements: โ€ข Chemical Moiety: Propranolol โ€ข Software: Phoenix TM , WinNonlin (subscription) & trial version also used. Theory: WinNonlin software are calculates the pk/pd of drug. Propranolol is beta-blocker uses to treat hypertension, angina & arrhythmias. To calculate its Pk/Pd through WinNonlin software. The basics steps of software to determine the PK/PD value with WinNonlin software as following: โˆ’ Import the data into the WinNonlin software. โˆ’ Select the appropriate PK/PD Model โˆ’ Fit the model to your data โˆ’ Evaluate the model fit โˆ’ Calculate the PK/PD parameter โˆ’ Generate the reports 01) Import the data into the WinNonlin software: Import the data into the formats, including CVS, Excel and Text Files.
  • 2. M. Pharm (Pharmaceutics) 2 02) Selecting the appropriate pk/pd model: The type of pk/pd selected depends on the drug and the data have. Some common model as follows: - One compartment Model - Two compartment Model - Michaelis-Menten Model - Emax. Model. 03) Fitting the model to data: WinNonlin uses variety of methods to fit the models to data, including least squares methods & the maximum likelihood methods. 04) Evaluating the model fit: When fit the model to data, need to evaluate the model fit. This done by locking at the residual plots and the R-squared values. 05) Calculating the pk/pd parameter: When evaluation had done of model fit, then calculate the pk/pd parameters. These parameters tell the drug how much absorbed, distribute, metabolized and eliminated. 06) Generating the reports: WinNonlin can generate a variety of reports in tables, graphs 7 figure. These reports can use to communicate the result of analysis to others. EXPERIMENTAL PROCEDURE: The procedure to determine the PK/PD in the software as following: 01. Import the Data: Open WinNonlin, click on the โ€œfileโ€ menu & select the โ€œimport Dataโ€. - Select the โ€œtableโ€ option & click on the โ€œnext buttonโ€. - Select the CSV file that contains your data & click on the โ€œopenโ€ button. - The data will be imported into the WinNonlin in a table. Sr. No. Time (hr.) Concentration (mg/mL) 1 0 100 2 1 80 3 2 60 4 3 40 5 4 20 6 5 00
  • 3. M. Pharm (Pharmaceutics) 3 02. Selecting the appropriate pk/pd model: One compartment model: ADME of drug are rapidly absorbed & distributed throughout the body. Two compartment model: ADME of drug are slowly absorbed & distributed throughout the body. Michaelis Menten Model: The Relation between the drug conc. & response. It describes the rate of enzymatic reaction. Emax. Model: Similar to the Michaelis equation, describes the max. response that drug achieved. Drug Type Appropriate pk/Pd Model Example Rapidly absorption/distribution One compartmental model Aminoglycosides. Warfarin, propranolol, insulin Slowly absorption/distribution Two compartmental model Digoxin, phenytoin, theophylline Drug with a clear dose response relationship Michaelis Menten equation Warfarin, penicillin, acetylcholinesterase Drug with an all-or- none response Emax. Aspirin, chlorpheniramine, epinephrine and nifedipine 03. Fitting the Appropriate Model to data: Here some of the steps as follows: a) Open WinNonlin software & create the new project: Go to โ€œFileโ€>New>Project. In the project dialog box, select the modeling project type & click Ok. b) Import the plasma conc. & time data into WinNonlin Software: Go to โ€œFile > Import. In the import dialog box, select the one compartment model type & click Ok. c) Create the One compartment model in WinNonlin Software: Go to Model > New Model. In the new model dialog box., select the one compartment model & click Ok. d) Fill the model to the using data the Non-Linear Regression tools in WinNonlin Software: Go to model>, in the fit dialog bx, select the non-linear regression tab. In the model field, select the one compartment model that, created in step. 3. In the data field, select the plasma conc. data that you imported in step. 2, click Ok. e) Evaluate the fit of model to data: Go to โ€œView> Fit result, Fit the results the dialog box will show you the result of non-linear regression fit. Evaluate the fit of model to data.
  • 4. M. Pharm (Pharmaceutics) 4 f) Save the model & result. 04. Evaluating the Model Fit: - Residual plots: Good randomly scattered around the line of zero. - R- Squared Value: A high R2 Value (closer to 1) indicate- Good Fit. - Low R2 Value (closer to 0) indicate โ€“ Poor fit. - AIC/BIC: Lowest AIC/BIC mean best fit. - Visual Inspection: Smooth Curve. 05. Calculating the PK/PD parameters: - Cl = Dose/AUC - Vd= AUC/Cmax. โ€“ AUC calculate by the go to. - T1/2 = 1H (2)/Cl โ€“ โ€œView> Area Under Curveโ€. The area under curve dialog box show AUC for the fitted model. 06. Generating Reports: The reports generate d of Pk reports includes ADME of drug. - PD reports for relationship between the drug plasma conc. & effect on blood pressure. - Safety reports. Result: The PK/PD of given beta-blocker propranolol drug has been calculated & graph will plot carefully. Pharmacokinetics parameters Value of parameters of drug Cl 10L/h Vd 50L (4L/kg) Mean Plasma concentration 100mg/mL Standard deviation 20mg/mL